Skip to main content

Carr Patricia's Form 4 filing

Jazz Pharmaceuticals plc (JAZZ) · filed Dec 9, 2025

Accession no.
0001784606-25-000007
Filed
Dec 9, 2025
Trade date
Dec 5, 2025
Filing delay
4 days
Rule 10b5-1 plan
Not checked

This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $797.8K. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Carr PatriciaCIK 0001784606Officer (SVP, Chief Accounting Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Dec 5, 2025Ordinary SharesSSaleDisposed−160$171.11−$27,377.67,012Direct
Dec 5, 2025Ordinary SharesMOption exerciseAcquired+4,500$140.67+$633,01511,512Direct
Dec 5, 2025Ordinary SharesSSaleDisposed−4,500$171.20−$770,4007,012Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Dec 5, 2025Ordinary SharesMOption exerciseDisposed−4,500$0.00$00Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)